While dysregulation of the microbiota may lead to activation of IL-17-producing cells which can translocate to the lung to cause pathology locally, the same type of IL-17+ T cells may also be protective in early stages of infection, as shown in preclinical mouse models of pulmonary infections (reviewed by Das and Khader in Das and Khader, 2017). Here, IL17A is linked to infection.